Revance Therapeutics' IPO

Revance Therapeutics raised a round of funding on February 06, 2014. Investors include Public.

Revance Therapeutics is a privately held specialty biopharmaceutical company which develops next generation products in dermatology and therapeutic medicine. Revance has developed a platform technolog…

Articles about Revance Therapeutics' IPO: